The K2 Principal Fund L.P.

The K2 Principal Fund L.P. discloses dealings in Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) to SEDI. In total, 15 filings cover trades dated from 18 January 2016 to 5 February 2016.

Both buying and selling appear: 8 purchases worth €144k, against 6 sales worth €21k. The net balance comes to €123k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €15k. Across 7 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 8 February 2016 with a transaction in Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.). The last purchase on record was published on 5 February 2016, which is 3,915 days ago. Filings reach the SEDI feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.